Idiopathic inflammatory-demyelinating diseases of the central nervous system

被引:0
作者
A. Rovira Cañellas
A. Rovira Gols
J. Río Izquierdo
M. Tintoré Subirana
X. Montalban Gairin
机构
[1] Vall d’Hebron University Hospital,Magnetic Resonance Unit (I.D.I.), Department of Radiology
[2] Parc Taulí University Institute - UAB,UDIAT, Diagnostic Centre
[3] Vall d’Hebron University Hospital,Neuroimmunology Unit, Department of Neurology
来源
Neuroradiology | 2007年 / 49卷
关键词
Multiple sclerosis; Magnetic resonance imaging; Brain diseases;
D O I
暂无
中图分类号
学科分类号
摘要
Idiopathic inflammatory-demyelinating diseases (IIDDs) include a broad spectrum of central nervous system disorders that can usually be differentiated on the basis of clinical, imaging, laboratory and pathological findings. However, there can be a considerable overlap between at least some of these disorders, leading to misdiagnoses or diagnostic uncertainty. The relapsing-remitting and secondary progressive forms of multiple sclerosis (MS) are the most common IIDDs. Other MS phenotypes include those with a progressive course from onset (primary progressive and progressive relapsing) or with a benign course continuing for years after onset (benign MS). Uncommon forms of IIDDs can be classified clinically into: (1) fulminant or acute IIDDs, such as the Marburg variant of MS, Baló’s concentric sclerosis, Schilder’s disease, and acute disseminated encephalomyelitis; (2) monosymptomatic IIDDs, such as those involving the spinal cord (transverse myelitis), optic nerve (optic neuritis) or brainstem and cerebellum; and (3) IIDDs with a restricted topographical distribution, including Devic’s neuromyelitis optica, recurrent optic neuritis and relapsing transverse myelitis. Other forms of IIDD, which are classified clinically and radiologically as pseudotumoral, can have different forms of presentation and clinical courses. Although some of these uncommon IIDDs are variants of MS, others probably correspond to different entities. MR imaging of the brain and spine is the imaging technique of choice for diagnosing these disorders, and together with the clinical and laboratory findings can accurately classify them. Precise classification of these disorders may have relevant prognostic and treatment implications, and might be helpful in distinguishing them from tumoral or infectious lesions, avoiding unnecessary aggressive diagnostic or therapeutic procedures.
引用
收藏
页码:393 / 409
页数:16
相关论文
共 466 条
[1]  
Brinar VV(2004)Non-MS recurrent demyelinating diseases Clin Neurol Neurosurg 106 197-210
[2]  
Fukazawa T(2004)Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders J Neurol Sci 225 71-78
[3]  
Kikuchi S(1992)Acute demyelinating disease. Classification and non-invasive diagnosis Acta Neurol Scand 86 579-585
[4]  
Niino M(2006)MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation” Lancet Neurol 5 841-852
[5]  
Poser S(1996)Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 907-911
[6]  
Luer W(1999)Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors J Neurol Neurosurg Psychiatry 67 148-152
[7]  
Bruhn H(2004)Disability profile of MS did not change over 10 years in a population-based prevalence cohort Neurology 62 601-606
[8]  
Frahm J(2004)Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study Ann Neurol 56 303-306
[9]  
Bruck Y(2002)A longitudinal study of abnormalities on MRI and disability from multiple sclerosis N Engl J Med 346 158-164
[10]  
Felgenhauer K(2002)Multiple sclerosis Lancet 359 1221-1231